What factors determine the effectiveness of drug delivery nanoparticles in different settings? The lack of a good way to answer that question has potentially held back a technology with the potential to improve the risk-benefit profile of cancer therapies. Recognizing that, researchers at Massachusetts Institute of Technology have run a large-scale screen to show how cancer cells respond to nanoparticles.
Hire with SEC
Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.
"*" indicates required fields